The antimicrobial susceptibilities of 16,441 gonococcal isolates from Seattle-King County were determined for ceftriaxone, cefoxitin, penicillin G, and tetracycline. From 1985 to 1989, ceftriaxone, in combination with doxycycline, was increasingly used for treatment of gonorrhea, and by 1989, it was used as therapy for >80% of cases in Seattle-King County. MICs of ceftriaxone correlated significantly (P < 0.001) with those of the other beta-lactam antibiotics included in this study. Geometric mean MICs of penicillin G for isolates that did not produce -lactamase increased from 1985 to 1991. The geometric mean MICs of cefoxitin, ceftriaxone, and tetracycline began to decline in 1987 but increased in 1990 and 1991. The percentage of strains with decreased susceptibility to ceftriaxone (MIC, 0.06 to 0.25 g/ml) rose from 0.3% in 1985 to 5.3% in 1987 but subsequently declined steadily to 2.6% in 1991, despite increased use of ceftriaxone as routine therapy for gonorrhea. Changes in patterns of antimicrobial susceptibility may be related not only to antimicrobial selection pressures but also to less well understood population shifts among Neisseria gonorrhoeae strains within a community.Neisseria gonorrhoeae has consistently developed resistance to the antimicrobial agents used for the treatment of gonorrhea (23). An excellent example of the effects of antibiotic selection pressure occurred in Korea, where penicillin resistance prompted primary therapy with spectinomycin, only to be followed by development of resistance to this antibiotic (1).In 1989, the Centers for Disease Control (Atlanta, Ga.) recommended ceftriaxone given as a single intramuscular dose of 250 mg as primary therapy for gonorrhea (3). Although a 125-mg dose of ceftriaxone had proven effective in clinical trials (8, 15), it was not widely recommended because of concern regarding the development of resistance to this antimicrobial agent with the use of the smaller dose (3). However, the Seattle-King County Department of Public Health Sexually Transmitted Diseases (STD) Clinic at Harborview Medical Center employed ceftriaxone in a dose of 125 mg given intramuscularly, followed by doxycycline, 100 mg twice daily by mouth for 7 days, since 1985. By mid-1987, this regimen became the standard therapy for gonorrhea in the STD clinic. By 1989, over 80% of the gonorrhea cases in both public clinics and the private sector in Seattle-King County were treated with ceftriaxone and doxycycline, and this remained the most commonly used therapy for gonorrhea through 1991.A laboratory surveillance system for gonococcal antimicrobial susceptibility was implemented in Seattle-King County in late 1985, since which time Ͼ80% of gonococcal isolates from reported cases have been referred to the Neisseria Reference Laboratory for antimicrobial susceptibility testing. This surveillance system permitted the assessment of the relationship of widespread ceftriaxone therapy for gonorrhea to trends in susceptibility of N. gonorrhoeae to ceftriaxone and other antibiotics.
MATERI...